PVI
LUCD icon

Pine Valley Investments’s Lucid Diagnostics LUCD Stock Holding History

Pine Valley Investments’s Portfolio LUCD Stock Details LUCD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$39.4K Buy
34,283
+14,487
+73% +$18.4K ﹤0.01% 564
2025
Q4 		$21.6K Sell
19,796
-300
-1% -$335 ﹤0.01% 554
2025
Q3 		$20.3K Buy
20,096
+8,800
+78% +$9.61K ﹤0.01% 555
2025
Q2 		$13K Hold
11,296
– – ﹤0.01% 545
2025
Q1 		$16.8K Buy
+11,296
New +$13.6K ﹤0.01% 542

Other funds holding LUCD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
MCM
Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return

Pine Valley Investments's LUCD Position: Q1 2026 in Review

Pine Valley Investments increased its Lucid Diagnostics (LUCD) stake by 73% in Q1 2026, buying an estimated $18.4K and bringing the position to 34,283 shares worth $39.4K. The position accounts for ﹤0.01% of the portfolio, ranked #564.

Pine Valley Investments first reported a position in LUCD in Q1 2025 and has held it in 5 quarters since. 103 funds tracked by Wall St. Rank hold LUCD as of Q1 2026.

  • Pine Valley Investments held 34,283 shares of Lucid Diagnostics worth $39.4K as of Q1 2026.
  • Pine Valley Investments bought 14,487 Lucid Diagnostics shares in Q1 2026, an estimated $18.4K.
  • Lucid Diagnostics made up ﹤0.01% of Pine Valley Investments's portfolio in Q1 2026, its #564 holding.
  • Pine Valley Investments first reported a position in Lucid Diagnostics in Q1 2025 and has held it in 5 quarters since.
  • 103 funds tracked by Wall St. Rank held Lucid Diagnostics as of Q1 2026.

Based on Pine Valley Investments's 13F filing for Q1 2026, filed 8 Jun 2026.